Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and Vaccine Immunology 2010-01, Vol.17 (1), p.143-153
Hauptverfasser: Kim, Tai-Gyu, Kim, Chang-Hyun, Park, Jung-Sun, Park, Sung-Dong, Kim, Chung Kwon, Chung, Dong-Sup, Hong, Yong-Kil
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 153
container_issue 1
container_start_page 143
container_title Clinical and Vaccine Immunology
container_volume 17
creator Kim, Tai-Gyu
Kim, Chang-Hyun
Park, Jung-Sun
Park, Sung-Dong
Kim, Chung Kwon
Chung, Dong-Sup
Hong, Yong-Kil
description Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI       
doi_str_mv 10.1128/CVI.00292-09
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1128_CVI_00292_09</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21491351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-5f6a8789d1f57c3346abfdc673e2fe7ad44ab2e8105de334e4740aed8790697c3</originalsourceid><addsrcrecordid>eNpVkcuLFDEQh4Mo7kNvniVePG2vST_yuAjLsLsOrAiyireQSVemI0lnTNLK-teb3Rlfp6qivvoS-CH0gpJzSlvxZvV5fU5IK9uGyEfomA4DaxiXXx7_7gWlR-gk56-E9B0T_Ck6olIIKTt2jNI6hGWOPm6d0R5faVNiyvgjeF3cvMUl4jIBvpiLK0uICV9aC6bgaPEthPizXgY3Al5NdXIPrsonvbvDbsYav1-SmwFfexdDneII_hl6YrXP8PxQT9Gnq8vb1bvm5sP1enVx05iBsNIMlmnBhRypHbjpup7pjR0N4x20Frge-15vWhCUDCPUNfS8JxpGwSVhsl6cord7727ZBBgNzCVpr3bJBZ3uVNRO_b-Z3aS28btqBW0Jl1Xw-iBI8dsCuajgsgHv9QxxyaqlvaTdQCt4tgdNijknsH8eoUTdh6RqSOohJEXuvS___dhf-JBKBV7tgcltpx8ugdI5KDN6pyhXVNG-634BpRObgA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21491351</pqid></control><display><type>article</type><title>Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model</title><source>American Society for Microbiology</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kim, Tai-Gyu ; Kim, Chang-Hyun ; Park, Jung-Sun ; Park, Sung-Dong ; Kim, Chung Kwon ; Chung, Dong-Sup ; Hong, Yong-Kil</creator><creatorcontrib>Kim, Tai-Gyu ; Kim, Chang-Hyun ; Park, Jung-Sun ; Park, Sung-Dong ; Kim, Chung Kwon ; Chung, Dong-Sup ; Hong, Yong-Kil</creatorcontrib><description>Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI       </description><identifier>ISSN: 1556-6811</identifier><identifier>ISSN: 1556-679X</identifier><identifier>EISSN: 1556-679X</identifier><identifier>DOI: 10.1128/CVI.00292-09</identifier><identifier>PMID: 19889936</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Antineoplastic Agents - therapeutic use ; Brain Neoplasms - immunology ; Brain Neoplasms - therapy ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - immunology ; Dacarbazine - analogs &amp; derivatives ; Dacarbazine - therapeutic use ; Dendritic Cells - immunology ; Disease Models, Animal ; Drug Therapy, Combination - methods ; Female ; Glioma - immunology ; Glioma - therapy ; Humans ; Immunotherapy - methods ; Mice ; Mice, Inbred C57BL ; Survival Analysis ; T-Lymphocytes, Regulatory - immunology ; Vaccine Research</subject><ispartof>Clinical and Vaccine Immunology, 2010-01, Vol.17 (1), p.143-153</ispartof><rights>Copyright © 2010, American Society for Microbiology 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-5f6a8789d1f57c3346abfdc673e2fe7ad44ab2e8105de334e4740aed8790697c3</citedby><cites>FETCH-LOGICAL-c506t-5f6a8789d1f57c3346abfdc673e2fe7ad44ab2e8105de334e4740aed8790697c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812079/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812079/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3175,3176,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19889936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Tai-Gyu</creatorcontrib><creatorcontrib>Kim, Chang-Hyun</creatorcontrib><creatorcontrib>Park, Jung-Sun</creatorcontrib><creatorcontrib>Park, Sung-Dong</creatorcontrib><creatorcontrib>Kim, Chung Kwon</creatorcontrib><creatorcontrib>Chung, Dong-Sup</creatorcontrib><creatorcontrib>Hong, Yong-Kil</creatorcontrib><title>Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model</title><title>Clinical and Vaccine Immunology</title><addtitle>Clin Vaccine Immunol</addtitle><description>Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI       </description><subject>Animals</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Brain Neoplasms - immunology</subject><subject>Brain Neoplasms - therapy</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Dacarbazine - analogs &amp; derivatives</subject><subject>Dacarbazine - therapeutic use</subject><subject>Dendritic Cells - immunology</subject><subject>Disease Models, Animal</subject><subject>Drug Therapy, Combination - methods</subject><subject>Female</subject><subject>Glioma - immunology</subject><subject>Glioma - therapy</subject><subject>Humans</subject><subject>Immunotherapy - methods</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Survival Analysis</subject><subject>T-Lymphocytes, Regulatory - immunology</subject><subject>Vaccine Research</subject><issn>1556-6811</issn><issn>1556-679X</issn><issn>1556-679X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkcuLFDEQh4Mo7kNvniVePG2vST_yuAjLsLsOrAiyireQSVemI0lnTNLK-teb3Rlfp6qivvoS-CH0gpJzSlvxZvV5fU5IK9uGyEfomA4DaxiXXx7_7gWlR-gk56-E9B0T_Ck6olIIKTt2jNI6hGWOPm6d0R5faVNiyvgjeF3cvMUl4jIBvpiLK0uICV9aC6bgaPEthPizXgY3Al5NdXIPrsonvbvDbsYav1-SmwFfexdDneII_hl6YrXP8PxQT9Gnq8vb1bvm5sP1enVx05iBsNIMlmnBhRypHbjpup7pjR0N4x20Frge-15vWhCUDCPUNfS8JxpGwSVhsl6cord7727ZBBgNzCVpr3bJBZ3uVNRO_b-Z3aS28btqBW0Jl1Xw-iBI8dsCuajgsgHv9QxxyaqlvaTdQCt4tgdNijknsH8eoUTdh6RqSOohJEXuvS___dhf-JBKBV7tgcltpx8ugdI5KDN6pyhXVNG-634BpRObgA</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Kim, Tai-Gyu</creator><creator>Kim, Chang-Hyun</creator><creator>Park, Jung-Sun</creator><creator>Park, Sung-Dong</creator><creator>Kim, Chung Kwon</creator><creator>Chung, Dong-Sup</creator><creator>Hong, Yong-Kil</creator><general>American Society for Microbiology</general><general>American Society for Microbiology (ASM)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20100101</creationdate><title>Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model</title><author>Kim, Tai-Gyu ; Kim, Chang-Hyun ; Park, Jung-Sun ; Park, Sung-Dong ; Kim, Chung Kwon ; Chung, Dong-Sup ; Hong, Yong-Kil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-5f6a8789d1f57c3346abfdc673e2fe7ad44ab2e8105de334e4740aed8790697c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Brain Neoplasms - immunology</topic><topic>Brain Neoplasms - therapy</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Dacarbazine - analogs &amp; derivatives</topic><topic>Dacarbazine - therapeutic use</topic><topic>Dendritic Cells - immunology</topic><topic>Disease Models, Animal</topic><topic>Drug Therapy, Combination - methods</topic><topic>Female</topic><topic>Glioma - immunology</topic><topic>Glioma - therapy</topic><topic>Humans</topic><topic>Immunotherapy - methods</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Survival Analysis</topic><topic>T-Lymphocytes, Regulatory - immunology</topic><topic>Vaccine Research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Tai-Gyu</creatorcontrib><creatorcontrib>Kim, Chang-Hyun</creatorcontrib><creatorcontrib>Park, Jung-Sun</creatorcontrib><creatorcontrib>Park, Sung-Dong</creatorcontrib><creatorcontrib>Kim, Chung Kwon</creatorcontrib><creatorcontrib>Chung, Dong-Sup</creatorcontrib><creatorcontrib>Hong, Yong-Kil</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and Vaccine Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Tai-Gyu</au><au>Kim, Chang-Hyun</au><au>Park, Jung-Sun</au><au>Park, Sung-Dong</au><au>Kim, Chung Kwon</au><au>Chung, Dong-Sup</au><au>Hong, Yong-Kil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model</atitle><jtitle>Clinical and Vaccine Immunology</jtitle><addtitle>Clin Vaccine Immunol</addtitle><date>2010-01-01</date><risdate>2010</risdate><volume>17</volume><issue>1</issue><spage>143</spage><epage>153</epage><pages>143-153</pages><issn>1556-6811</issn><issn>1556-679X</issn><eissn>1556-679X</eissn><abstract>Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI       </abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>19889936</pmid><doi>10.1128/CVI.00292-09</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1556-6811
ispartof Clinical and Vaccine Immunology, 2010-01, Vol.17 (1), p.143-153
issn 1556-6811
1556-679X
1556-679X
language eng
recordid cdi_crossref_primary_10_1128_CVI_00292_09
source American Society for Microbiology; MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects Animals
Antineoplastic Agents - therapeutic use
Brain Neoplasms - immunology
Brain Neoplasms - therapy
CD4-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - immunology
Dacarbazine - analogs & derivatives
Dacarbazine - therapeutic use
Dendritic Cells - immunology
Disease Models, Animal
Drug Therapy, Combination - methods
Female
Glioma - immunology
Glioma - therapy
Humans
Immunotherapy - methods
Mice
Mice, Inbred C57BL
Survival Analysis
T-Lymphocytes, Regulatory - immunology
Vaccine Research
title Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T15%3A51%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunological%20Factors%20Relating%20to%20the%20Antitumor%20Effect%20of%20Temozolomide%20Chemoimmunotherapy%20in%20a%20Murine%20Glioma%20Model&rft.jtitle=Clinical%20and%20Vaccine%20Immunology&rft.au=Kim,%20Tai-Gyu&rft.date=2010-01-01&rft.volume=17&rft.issue=1&rft.spage=143&rft.epage=153&rft.pages=143-153&rft.issn=1556-6811&rft.eissn=1556-679X&rft_id=info:doi/10.1128/CVI.00292-09&rft_dat=%3Cproquest_cross%3E21491351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21491351&rft_id=info:pmid/19889936&rfr_iscdi=true